Evidence map›Paper›PMID 27857884›Full record

ArticleClinical cancer drugs2016

Tumor-selective cytotoxicity of a novel pentadiene analogue on human leukemia/ lymphoma cells.

Yahaira Santiago-Vázquez, Umashankar Das, Armando Varela-Ramirez, Sarah T Baca, Yoshira Ayala-Marin, Carolina Lema, Swagatika Das, Alaa Baryyan, Jonathan R Dimmock, Renato J Aguilera

Abstract read
In one paragraph

Article in Clinical cancer drugs, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Design, Syntheses, and Bioevaluations of Some NovelMedicines (Basel, Switzerland) · 2021
    Article
  8. Article
  9. Dienone Compounds: Targets and Pharmacological Responses.Journal of medicinal chemistry · 2020
    Article
  10. Article
  11. Article
  12. Article
  13. Antioxidants (Basel, Switzerland) · 2019
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Aquaporins as Targets of Dietary Bioactive Phytocompounds.Frontiers in molecular biosciences · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yahaira Santiago-VázquezDepartment of Biological Sciences, Bioscience Research Building, Border Biomedical Research Center, Cytometry, Screening and Imaging Core Facility, University of Texas at El Paso, Texas, 79968, USA.
Umashankar DasCollege of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, Saskatchewan, S7N 5C9, Canada.
Armando Varela-RamirezDepartment of Biological Sciences, Bioscience Research Building, Border Biomedical Research Center, Cytometry, Screening and Imaging Core Facility, University of Texas at El Paso, Texas, 79968, USA.
Sarah T BacaDepartment of Biological Sciences, Bioscience Research Building, Border Biomedical Research Center, Cytometry, Screening and Imaging Core Facility, University of Texas at El Paso, Texas, 79968, USA.
Yoshira Ayala-MarinDepartment of Biological Sciences, Bioscience Research Building, Border Biomedical Research Center, Cytometry, Screening and Imaging Core Facility, University of Texas at El Paso, Texas, 79968, USA.
Carolina LemaDepartment of Biological Sciences, Bioscience Research Building, Border Biomedical Research Center, Cytometry, Screening and Imaging Core Facility, University of Texas at El Paso, Texas, 79968, USA; College of Optometry, University of Houston, 4901 Calhoun Road, Houston, TX, 77204, USA.
Swagatika DasCollege of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, Saskatchewan, S7N 5C9, Canada.
Alaa BaryyanCollege of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, Saskatchewan, S7N 5C9, Canada.
Jonathan R DimmockCollege of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, Saskatchewan, S7N 5C9, Canada.
Renato J AguileraDepartment of Biological Sciences, Bioscience Research Building, Border Biomedical Research Center, Cytometry, Screening and Imaging Core Facility, University of Texas at El Paso, Texas, 79968, USA.

Funding

TCCG12MD007592 · NIMHD · UNIVERSITY OF TEXAS EL PASO · PI KIRKEN, ROBERT A. · 2012 to 2018
$19.4M
RISE Scholars Program at UTEPR25GM069621 · NIGMS · UNIVERSITY OF TEXAS EL PASO · PI AGUILERA, RENATO J · 2004 to 2021
$11.2M
Characterization of novel compounds with anti-lymphoma activitySC3GM103713 · NIGMS · UNIVERSITY OF TEXAS EL PASO · PI AGUILERA, RENATO J · 2013 to 2016
$453k
NIGMS NIH HHS R25 GM069621NIGMS NIH HHS SC3 GM103713NIMHD NIH HHS G12 MD007592
6 · The paper itself

Abstract

backgroundA novel series of structurally divergent 1,5-diaryl-3-oxo-1,4-pentadiene analogues

objectiveTo identify novel selective cytotoxic compounds that induce apoptosis.

methodsThe Differential Nuclear Staining (DNS) screening protocol was utilized to measure the cytotoxicity of all experimental dienones on several cancerous cells. Additionally, the selective cytotoxicity index was calculated by comparing the dienone's cytotoxicity between leukemia/lymphoma cells vs. non-cancerous cells. Furthermore, to discern whether a selected dienone induced cell death

resultsThe dienones were tested for their anti-neoplastic efficiency on human leukemia/lymphoma-derived cell lines. Special emphasis was applied on dienone

conclusionThe novel dienone

Indexed as

ApoptosisCancerCaspase 3Curcumin analogueCytotoxinsLeukemiaMitochondria

Identifiers

PMID27857884
PMCPMC5110259

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.